The impact of fluticasone furoate/vilanterol on healthcare resource utilisation in the Salford Lung Study in chronic obstructive pulmonary disease

AIM: The Salford Lung Study (SLS) in chronic obstructive pulmonary disease (COPD) was a randomised controlled trial evaluating the effectiveness and safety of initiating fluticasone furoate/vilanterol (FF/VI) 100/25 µg versus continuing usual care (UC) in patients with COPD and a history of exacerba...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakerly, Nawar Diar, Browning, Dominy, Boucot, Isabelle, Crawford, Jodie, McCorkindale, Sheila, Stein, Norman, New, John P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013671/
https://www.ncbi.nlm.nih.gov/pubmed/33781142
http://dx.doi.org/10.1177/17534666211001013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8013671/
https://www.ncbi.nlm.nih.gov/pubmed/33781142
http://dx.doi.org/10.1177/17534666211001013

Ejemplares similares